MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach-Reference-Cited by-同舟云学术

MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach

Published:2021-07-02 Issue:11 Volume:51 Page:1115-1128
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Tsutsumi Tsubasa¹^ORCID,Eslam Mohammed²,Kawaguchi Takumi¹^ORCID,Yamamura Sakura¹^ORCID,Kawaguchi Atsushi³,Nakano Dan¹^ORCID,Koseki Masahiro⁴,Yoshinaga Shinobu⁵,Takahashi Hirokazu⁶⁷^ORCID,Anzai Keizo⁶,George Jacob²,Torimura Takuji¹^ORCID

Affiliation:

1. Division of Gastroenterology Department of Medicine Kurume University School of Medicine Kurume Japan

2. Storr Liver Centre Westmead Institute for Medical Research Westmead Hospital and University of Sydney New South Wales Australia

3. Education and Research Center for Community Medicine Faculty of Medicine, Saga University Saga Japan

4. Division of Cardiovascular Medicine Department of Medicine Osaka University Graduate School of Medicine Osaka Japan

5. Medical Examination Section Medical Examination Part Facilities Public Utility Foundation Saga Prefectural Health Promotion Foundation Saga Japan

6. Division of Metabolism and Endocrinology Faculty of Medicine Saga University Saga Japan

7. Liver Center Saga University Hospital Saga Japan

Funder

Japan Agency for Medical Research and Development

National Health and Medical Research Council

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13685

Reference42 articles.

1. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

2. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

3. Non-alcoholic fatty liver disease – A global public health perspective

4. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

5. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Non-Obese Steatohepatitis Mouse Model with Cardiac Dysfunction Induced by Addition of Ethanol to a High-Fat/High-Cholesterol Diet;Biology;2024-02-01

2. Pre-MASLD: Should it be defined separately?;Hepatobiliary & Pancreatic Diseases International;2024-02

3. Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease;Hepatology Research;2024-01-31

4. Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!;Expert Opinion on Pharmacotherapy;2024-01-29

5. Advancements in metabolic‐associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions;Hepatology Research;2024-01-22